Cannvas launches Cannvas.Me, Cannabis Education Platform
Global Data-Driven Cannabis Education Platform Is Open for Business
TORONTO, Oct. 9, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce that Cannvas.Me, its first cannabis-centric service offering to the public, is now available online at https://Cannvas.Me.
“As the legalization of cannabis in Canada quickly approaches, Cannvas.Me fills the knowledge gap with credible information on the potential benefits of cannabis brought forth by physicians and certified educators,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “The Cannvas.Me educational portal has something for just about everybody with information available to users where and when they need it. Whether on a tablet in a medical clinic, at home on a desktop or anywhere on a mobile device, Cannvas.Me provides valuable educational content with no interference from LPs and no pressure to purchase or consume.”
The public is invited to explore Cannvas.Me today and learn about the potential health benefits from using cannabis in its various forms. The educational platform features a number of innovative modules and tools making cannabis education approachable and accessible to a global audience. Site features include:
- Cannvas Academy – educational learning modules created by medical practitioners and certified educators;
- Cannvas Strain Matcher – an interactive experience where users learn which strain is best for alleviating specific ailments;
- Cannvas Culinary – a culinary training module with recipes, ideas and more.
The team at Cannvas is working on additional modules and tools to be added to the platform as they become available. Canada is leading the transformation of the cannabis world through legalization and through the emergence of a significant economic force. By ensuring a best-in-class experience for all users, by utilizing machine-learning algorithms and artificial intelligence (AI) to contextualize and adapt as users navigate the website, and by presenting physician-backed information which has been vetted through a series of systems and reviews to ensure the most accurate and up-to-date information, Cannvas.Me is positioned to become the go-to source for cannabis information and educational content.
“We have made considerable progress in the past 12 months coming from a brand new company with two team members to launching our first online cannabis-centric educational platform with over 20 team members,” said Steve Loutskou, Chief Executive Officer of Cannvas Cannabis Acquisitions and Chief Operating Officer, Global Markets at Cannvas MedTech. “We will continue to work diligently toward adding new and exciting modules to Cannvas.Me to become the premiere source for cannabis information.”
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: www.cannvasmedtech.com; Media Inquiries: email@example.com; Investor Relations: firstname.lastname@example.org, 1-800-489-0116